UK markets close in 3 hours 26 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
124.06-1.08 (-0.87%)
At close: 04:00PM EDT
124.30 +0.25 (+0.20%)
Pre-market: 08:03AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 47.54B
Enterprise value 40.26B
Trailing P/E 7.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.30
Price/book (mrq)3.71
Enterprise value/revenue 7.92
Enterprise value/EBITDA 4.64

Trading information

Stock price history

Beta (5Y monthly) 1.66
52-week change 3-0.57%
S&P500 52-week change 323.23%
52-week high 3170.47
52-week low 362.55
50-day moving average 3135.40
200-day moving average 3105.07

Share statistics

Avg vol (3-month) 34.02M
Avg vol (10-day) 33.09M
Shares outstanding 5383.24M
Implied shares outstanding 6383.24M
Float 8345.89M
% held by insiders 19.56%
% held by institutions 173.19%
Shares short (28 Jun 2024) 422.13M
Short ratio (28 Jun 2024) 45.18
Short % of float (28 Jun 2024) 47.60%
Short % of shares outstanding (28 Jun 2024) 45.77%
Shares short (prior month 31 May 2024) 420.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin -115.82%
Operating margin (ttm)-758.08%

Management effectiveness

Return on assets (ttm)-15.72%
Return on equity (ttm)-37.68%

Income statement

Revenue (ttm)5.15B
Revenue per share (ttm)13.52
Quarterly revenue growth (yoy)-91.00%
Gross profit (ttm)N/A
Net income avi to common (ttm)-5.97B
Diluted EPS (ttm)-15.61
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.52B
Total cash per share (mrq)22.24
Total debt (mrq)1.24B
Total debt/equity (mrq)9.65%
Current ratio (mrq)4.03
Book value per share (mrq)33.47

Cash flow statement

Operating cash flow (ttm)-2.88B
Levered free cash flow (ttm)-1.95B